Sanofi (SNY)
Sanofi Statistics
Share Statistics
Sanofi has 2.45B shares outstanding. The number of shares has increased by -2.3% in one year.
Shares Outstanding | 2.45B |
Shares Change (YoY) | -2.3% |
Shares Change (QoQ) | -1.9% |
Owned by Institutions (%) | 21.08% |
Shares Floating | 2.45B |
Failed to Deliver (FTD) Shares | 45 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 41.93 and the forward PE ratio is 10.58. Sanofi's PEG ratio is -0.86.
PE Ratio | 41.93 |
Forward PE | 10.58 |
PS Ratio | 5.26 |
Forward PS | 2.1 |
PB Ratio | 3.01 |
P/FCF Ratio | 39.61 |
PEG Ratio | -0.86 |
Enterprise Valuation
Sanofi has an Enterprise Value (EV) of 127.03B.
EV / Sales | 2.87 |
EV / EBITDA | 11.51 |
EV / EBIT | 13.99 |
EV / FCF | 21.58 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.46 |
Quick Ratio | 1.14 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.62 |
Debt / FCF | 3.04 |
Interest Coverage | 9.68 |
Financial Efficiency
Return on Equity is 7.17% and Return on Invested Capital is 5.5%.
Return on Equity | 7.17% |
Return on Assets | 4.19% |
Return on Invested Capital | 5.5% |
Revenue Per Employee | $534.35K |
Profits Per Employee | $67.09K |
Employee Count | 82,878 |
Asset Turnover | 0.33 |
Inventory Turnover | 1.4 |
Taxes
Income Tax | 1.2B |
Effective Tax Rate | 17.98% |
Stock Price Statistics
The stock price has increased by 13.73% in the last 52 weeks. The beta is 0.48, so Sanofi's price volatility has been higher than the market average.
Beta | 0.48 |
52-Week Price Change | 13.73% |
50-Day Moving Average | 54.79 |
200-Day Moving Average | 52.94 |
Relative Strength Index (RSI) | 50.2 |
Average Volume (20 Days) | 2.88M |
Income Statement
In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 2.22.
Revenue | 44.29B |
Gross Profit | 31.08B |
Operating Income | 7.25B |
Net Income | 5.56B |
EBITDA | 11.03B |
EBIT | 7.45B |
Earnings Per Share (EPS) | 2.22 |
Balance Sheet
The company has 7.44B in cash and 17.91B in debt, giving a net cash position of -10.46B.
Cash & Cash Equivalents | 7.44B |
Total Debt | 17.91B |
Net Cash | -10.46B |
Retained Earnings | 0 |
Total Assets | 132.8B |
Working Capital | 13.43B |
Cash Flow
In the last 12 months, operating cash flow was 9.08B and capital expenditures -3.19B, giving a free cash flow of 5.89B.
Operating Cash Flow | 9.08B |
Capital Expenditures | -3.19B |
Free Cash Flow | 5.89B |
FCF Per Share | 2.35 |
Margins
Gross margin is 70.18%, with operating and profit margins of 16.38% and 12.55%.
Gross Margin | 70.18% |
Operating Margin | 16.38% |
Pretax Margin | 15.12% |
Profit Margin | 12.55% |
EBITDA Margin | 24.91% |
EBIT Margin | 16.38% |
FCF Margin | 13.29% |
Dividends & Yields
SNY pays an annual dividend of $3.65, which amounts to a dividend yield of 3.1%.
Dividend Per Share | $3.65 |
Dividend Yield | 3.1% |
Dividend Growth (YoY) | -21% |
Payout Ratio | 145.84% |
Earnings Yield | 2.38% |
FCF Yield | 5.05% |
Analyst Forecast
The average price target for SNY is $62.5, which is 17.9% higher than the current price. The consensus rating is "Buy".
Price Target | $62.5 |
Price Target Difference | 17.9% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Sep 30, 2013. It was a forward split with a ratio of 5:1.
Last Split Date | Sep 30, 2013 |
Split Type | forward |
Split Ratio | 5:1 |
Scores
Altman Z-Score | 2.05 |
Piotroski F-Score | 7 |